University at Buffalo (UB)
The State University
of New York
Jacobs School of Medicine
and Biomedical Sciences
Give
Apply

Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
  • Clinical and Translational Sciences Institute. Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences. $28,400,000. 1/1/2026-12/1/2032.
  • CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
  • Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
  • CTSA UM1 State University of New York at Buffalo. Bonnie Vest (Other). NIH. 1/1/2025-12/1/2031.
  • CTSA UM1 State University of New York at Buffalo. Praveen Chandrasekharan (Co-Investigator). NIH/NCATS. $29,204,726. 8/1/2025-7/1/2031.
  • Nef-independent SERINC5 regulation. Spyridon Stavrou (Principal Investigator). NIH/NIAID. $3,576,554. 7/1/2026-6/1/2031.
  • Efficacy of Continuous Glucose Monitoring Relative to Traditional Self-Monitoring of Blood Glucose in Non-Insulin Treated Adults with Poorly Controlled T2DM. Obinna Ekwunife (Co-Investigator). NIH/NIDDK. $3,998,816. 7/1/2026-6/1/2031.
  • Empowering older adults with type 2 diabetes using continuous glucose monitoring and health coaching for individualized, values-concordant care. Raphael Fraser (Principal Investigator). NIH/NIDDK. $3,749,950. 8/1/2026-6/1/2031.
  • Dissecting the role for astrocytes in mediating adverse outcomes of maternal immuneactivation. Samir Haj-Dahmane (Co-Principal Investigator). NIMH. $3,754,157. 6/1/2026-3/1/2031.
  • Polysaccharide utilization and antimicrobial resistance in abundant gut bacteria. Yolanda Huang (Principal Investigator). NIH NIGMS. $2,170,000. 3/1/2026-2/1/2031.
  • CTSA UM1 State University of New York at Buffalo. Gabriela Popescu (Co-Investigator). National Center for Advancing Translational Sciences. $3,710,000. 1/1/2025-1/1/2031.
  • The UB Primary Care Training and Enhancement – Residency Training in Street Medicine. Brian Clemency (Co-Investigator). HRSA. $2,500,000. 9/1/2025-9/1/2030.
  • Structure and assembly of membrane proteins at tight junctions. Alex Vecchio (Principal Investigator). NIH/NIGMS. $2,166,105. 9/1/2025-8/1/2030.
  • Mechanisms of Heat Sensing by Nociceptive Vanilloid Receptors (Award 106744). Feng Qin (Principal Investigator). NIH. $2,178,335. 8/1/2026-8/1/2030.